JPM vs UMBF

JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.

UMBF presents a compelling value opportunity, characterized by a Piotroski F-Score of 4/9 (Stable) and a current price ($123.04) trading significantly below both its Graham Number ($142.0) and Intrinsic Value ($238.28). The company is demonstrating explosive top-line momentum with 67.6% YoY revenue growth and a highly consistent track record of earnings beats over the last 25 quarters. While insider selling and a bearish technical trend create short-term friction, the low Forward P/E of 9.33 and a conservative dividend payout ratio of 17.55% indicate strong fundamental health and growth potential. The valuation gap suggests the market is underpricing the company's current growth trajectory.